These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35478139)

  • 1. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
    Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
    In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
    Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
    Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
    Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
    Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
    Zou DD; Sun YZ; Li XJ; Wu WJ; Xu D; He YT; Qi J; Tu Y; Tang Y; Tu YH; Wang XL; Li X; Lu FY; Huang L; Long H; He L; Li X
    Elife; 2023 Dec; 12():. PubMed ID: 38099574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
    Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
    Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
    Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
    J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis.
    Lee JS; Park HS; Yoon HS; Cho S
    Clin Exp Dermatol; 2019 Jul; 44(5):483-490. PubMed ID: 30315595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
    Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
    Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition contributes to invasion in squamous cell carcinomas originated from actinic keratosis through the differentiated pathway, whereas proliferation plays a more significant role in the classical pathway.
    Saenz-Sardà X; Carrato C; Pérez-Roca L; Puig L; Ferrándiz C; Ariza A; Fernández-Figueras MT
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):581-586. PubMed ID: 28796927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
    Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
    Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
    Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
    An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients.
    Shibayama Y; Imafuku S
    J Dermatol; 2014 Dec; 41(12):1102-5. PubMed ID: 25385075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.
    Ratushny V; Gober MD; Hick R; Ridky TW; Seykora JT
    J Clin Invest; 2012 Feb; 122(2):464-72. PubMed ID: 22293185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis].
    Dornelas MT; Rodrigues MF; Machado DC; Gollner AM; Ferreira AP
    An Bras Dermatol; 2009; 84(5):469-75. PubMed ID: 20098848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma.
    Vîlcea AM; Stoica LE; Andreiana BC; Mirea CS; Ţenea Cojan TŞ; Vîlcea IC; Mărgăritescu C
    Rom J Morphol Embryol; 2024; 65(1):19-25. PubMed ID: 38527980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.
    Zamirska A; Matusiak Ł; Dziegiel P; Szybejko-Machaj G; Szepietowski JC
    Pathol Oncol Res; 2012 Oct; 18(4):849-55. PubMed ID: 22407324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.